Prognostic Factors and Life Expectancy in Canine Leishmaniosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.19/6936 |
Resumo: | Canine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis. This study aims to estimate the survival time of dogs with CanL, determining the prognostic value of different clinical and clinicopathological parameters. Medical records of 99 dogs diagnosed with CanL in five veterinary centers of the Alentejo region (Portugal) were examined retrospectively. The majority of dogs presented hyperproteinemia, moderate normocytic normochromic anemia, normal blood urea and creatinine levels and were classified as stage 1 according to the International Interest Society (IRIS) guidelines at the time of diagnosis. The severity of anemia, presence of concomitant infectious diseases at the time of diagnosis and the anti-Leishmania therapy were correlated with the survival time. The influence of renal dysfunction was evaluated by Receiver Operating Characteristic (ROC) curve and survival analysis. Survival analysis demonstrated that patients classified as IRIS 1 at the time of diagnosis survived more than four years, in contrast with dogs classified as IRIS 2 that survived around two and half years and dogs classified as IRIS 3–4 that survived around one month. IRIS stage deteriorated during the course of CanL in one third of the dogs and was the principal cause of death or euthanasia in a high proportion of animals. In some cases, dogs did not receive anti-Leishmania treatment or abandoned the veterinary follow-ups, which may have considerable repercussions for animal wellbeing and public health. This study reinforces the value of blood urea and creatinine levels as prognostic factors in CanL. |
id |
RCAP_3b75074f0214806e14edc26d7ac2ae75 |
---|---|
oai_identifier_str |
oai:repositorio.ipv.pt:10400.19/6936 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Prognostic Factors and Life Expectancy in Canine Leishmaniosiscanine leishmaniosisprognostic factorssurvival timeIRIS stagingtherapy selection and managementCanine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis. This study aims to estimate the survival time of dogs with CanL, determining the prognostic value of different clinical and clinicopathological parameters. Medical records of 99 dogs diagnosed with CanL in five veterinary centers of the Alentejo region (Portugal) were examined retrospectively. The majority of dogs presented hyperproteinemia, moderate normocytic normochromic anemia, normal blood urea and creatinine levels and were classified as stage 1 according to the International Interest Society (IRIS) guidelines at the time of diagnosis. The severity of anemia, presence of concomitant infectious diseases at the time of diagnosis and the anti-Leishmania therapy were correlated with the survival time. The influence of renal dysfunction was evaluated by Receiver Operating Characteristic (ROC) curve and survival analysis. Survival analysis demonstrated that patients classified as IRIS 1 at the time of diagnosis survived more than four years, in contrast with dogs classified as IRIS 2 that survived around two and half years and dogs classified as IRIS 3–4 that survived around one month. IRIS stage deteriorated during the course of CanL in one third of the dogs and was the principal cause of death or euthanasia in a high proportion of animals. In some cases, dogs did not receive anti-Leishmania treatment or abandoned the veterinary follow-ups, which may have considerable repercussions for animal wellbeing and public health. This study reinforces the value of blood urea and creatinine levels as prognostic factors in CanL.Repositório Científico do Instituto Politécnico de ViseuPereira, Maria AiresSantos, RuteOliveira, RicardoCosta, LinaPrata, AnaGonçalves, VâniaRoquette, MadalenaVala, HelenaSantos-Gomes, Gabriela2021-12-17T13:53:40Z2020-09-042021-12-12T17:23:13Z2020-09-04T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.19/6936engPereira, M. A., Santos, R., Oliveira, R., Costa, L., Prata, A., Gonçalves, V., Roquette, M., Vala, H., & Santos-Gomes, G. (2020). Prognostic Factors and Life Expectancy in Canine Leishmaniosis. Veterinary Sciences, 7(3), 128. https://doi.org/10.3390/vetsci70301282306-7381cv-prod-259114010.3390/vetsci7030128info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-01-16T15:29:05Zoai:repositorio.ipv.pt:10400.19/6936Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:44:45.298795Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Prognostic Factors and Life Expectancy in Canine Leishmaniosis |
title |
Prognostic Factors and Life Expectancy in Canine Leishmaniosis |
spellingShingle |
Prognostic Factors and Life Expectancy in Canine Leishmaniosis Pereira, Maria Aires canine leishmaniosis prognostic factors survival time IRIS staging therapy selection and management |
title_short |
Prognostic Factors and Life Expectancy in Canine Leishmaniosis |
title_full |
Prognostic Factors and Life Expectancy in Canine Leishmaniosis |
title_fullStr |
Prognostic Factors and Life Expectancy in Canine Leishmaniosis |
title_full_unstemmed |
Prognostic Factors and Life Expectancy in Canine Leishmaniosis |
title_sort |
Prognostic Factors and Life Expectancy in Canine Leishmaniosis |
author |
Pereira, Maria Aires |
author_facet |
Pereira, Maria Aires Santos, Rute Oliveira, Ricardo Costa, Lina Prata, Ana Gonçalves, Vânia Roquette, Madalena Vala, Helena Santos-Gomes, Gabriela |
author_role |
author |
author2 |
Santos, Rute Oliveira, Ricardo Costa, Lina Prata, Ana Gonçalves, Vânia Roquette, Madalena Vala, Helena Santos-Gomes, Gabriela |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Instituto Politécnico de Viseu |
dc.contributor.author.fl_str_mv |
Pereira, Maria Aires Santos, Rute Oliveira, Ricardo Costa, Lina Prata, Ana Gonçalves, Vânia Roquette, Madalena Vala, Helena Santos-Gomes, Gabriela |
dc.subject.por.fl_str_mv |
canine leishmaniosis prognostic factors survival time IRIS staging therapy selection and management |
topic |
canine leishmaniosis prognostic factors survival time IRIS staging therapy selection and management |
description |
Canine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis. This study aims to estimate the survival time of dogs with CanL, determining the prognostic value of different clinical and clinicopathological parameters. Medical records of 99 dogs diagnosed with CanL in five veterinary centers of the Alentejo region (Portugal) were examined retrospectively. The majority of dogs presented hyperproteinemia, moderate normocytic normochromic anemia, normal blood urea and creatinine levels and were classified as stage 1 according to the International Interest Society (IRIS) guidelines at the time of diagnosis. The severity of anemia, presence of concomitant infectious diseases at the time of diagnosis and the anti-Leishmania therapy were correlated with the survival time. The influence of renal dysfunction was evaluated by Receiver Operating Characteristic (ROC) curve and survival analysis. Survival analysis demonstrated that patients classified as IRIS 1 at the time of diagnosis survived more than four years, in contrast with dogs classified as IRIS 2 that survived around two and half years and dogs classified as IRIS 3–4 that survived around one month. IRIS stage deteriorated during the course of CanL in one third of the dogs and was the principal cause of death or euthanasia in a high proportion of animals. In some cases, dogs did not receive anti-Leishmania treatment or abandoned the veterinary follow-ups, which may have considerable repercussions for animal wellbeing and public health. This study reinforces the value of blood urea and creatinine levels as prognostic factors in CanL. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-09-04 2020-09-04T00:00:00Z 2021-12-17T13:53:40Z 2021-12-12T17:23:13Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.19/6936 |
url |
http://hdl.handle.net/10400.19/6936 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Pereira, M. A., Santos, R., Oliveira, R., Costa, L., Prata, A., Gonçalves, V., Roquette, M., Vala, H., & Santos-Gomes, G. (2020). Prognostic Factors and Life Expectancy in Canine Leishmaniosis. Veterinary Sciences, 7(3), 128. https://doi.org/10.3390/vetsci7030128 2306-7381 cv-prod-2591140 10.3390/vetsci7030128 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130918634389504 |